ABBOTT REALTIME HCV AMPLIFICATION REAGENT KIT 1N30-90

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2018-05-24 for ABBOTT REALTIME HCV AMPLIFICATION REAGENT KIT 1N30-90 manufactured by Abbott Molecular, Inc..

Event Text Entries

[109229419] Complaint investigation will be performed. Note: lot, expiration, udi, manufacture date and pma number have been left blank as this mdr is being submitted on the basis that abbott realtime hcv amplification reagent kit (list 4j86-90) is similar to the abbott realtime hcv amplification reagent kit (list 1n30-90) sold in the united states. Ticket does not reference a us list 1n30-90 lot number.
Patient Sequence No: 1, Text Type: N, H10


[109229420] The abbott realtime hcv assay is an in vitro reverse transcription polymerase chain reaction (rt-pcr) assay for the quantitation of hepatitis c viral ribonucleic acid (hcv rna) in human serum and plasma from hcv-infected individuals. The abbott realtime hcv assay is intended for use as an aid in the management of hcv-infected patients undergoing antiviral therapy. The abbott realtime hcv assay is not for screening blood, plasma, serum or tissue donors for hcv, or to be used as a diagnostic test to confirm the presence of hcv infection. Customer called to report a false detected result on the realtime hcv assay. Customer is using our assay for tissue donor screening, which is outside the intended use of the assay per the package insert. Clarification received for claim of second sample in february with similar issue to mdr 3005248192-2018-00004. This case from february was a similar case of running the realtime hcv assay for screening of tissue donors. It is unknown if the result was compared to results received from other laboratories. Customer did not repeat that sample and tissue was discarded based on the detected realtime hcv assay result. The discarding of potential donor tissue due to a false detected result on the realtime hcv assay is regarded as a serious injury due to potential impact on unavailability of tissue for transplant, although the customer used the assay for tissue donor screening, which is outside the intended use of the assay per the package insert. There have been no reports of impact or harm to patient due to this issue. This incident is being reported to fda because the incident occurred in belgium using realtime hcv list number 4j86-90 which is same/similar to us fda approved realtime hcv list number 1n30-90.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3005248192-2018-00005
MDR Report Key7543091
Report SourceCOMPANY REPRESENTATIVE
Date Received2018-05-24
Date of Report2018-06-29
Date of Event2017-02-01
Date Mfgr Received2018-06-21
Date Added to Maude2018-05-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR JOE HUTSON
Manufacturer Street1300 E. TOUHY AVE.
Manufacturer CityDES PLAINES IL 600183315
Manufacturer CountryUS
Manufacturer Postal600183315
Manufacturer Phone2243617619
Manufacturer G1ABBOTT MOLECULAR, INC.
Manufacturer Street1300 E. TOUHY AVE.
Manufacturer CityDES PLAINES IL 600183315
Manufacturer CountryUS
Manufacturer Postal Code600183315
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameABBOTT REALTIME HCV AMPLIFICATION REAGENT KIT
Generic NameASSAY,HYBRIDIZATION AND/OR NUCLEIC ACID AMPLIFICATION FOR DETECTION OF HEPATITIS
Product CodeMZP
Date Received2018-05-24
Catalog Number1N30-90
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABBOTT MOLECULAR, INC.
Manufacturer Address1300 E. TOUHY AVE. DES PLAINES IL 600183315 US 600183315


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2018-05-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.